Evidence map›Paper›PMID 42712735›Full record

ArticleBeilstein journal of organic chemistry2026

Bismuth(III)-catalyzed three-component selenation of imidazo[1,2-

Naoki Aiba, Mio Matsumura, Yuki Tada, Yuki Murata, Shuji Yasuike

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Beilstein journal of organic chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Naoki AibaSchool of Pharmaceutical Sciences, Aichi Gakuin University, 1-100 Kusumoto-cho, Chikusa-ku, Nagoya 464-8650, Japan.
Mio MatsumuraSchool of Pharmaceutical Sciences, Aichi Gakuin University, 1-100 Kusumoto-cho, Chikusa-ku, Nagoya 464-8650, Japan.ORCID https://orcid.org/0000-0002-2675-4498
Yuki TadaSchool of Pharmaceutical Sciences, Aichi Gakuin University, 1-100 Kusumoto-cho, Chikusa-ku, Nagoya 464-8650, Japan.
Yuki MurataSchool of Pharmaceutical Sciences, Aichi Gakuin University, 1-100 Kusumoto-cho, Chikusa-ku, Nagoya 464-8650, Japan.ORCID https://orcid.org/0000-0002-8677-2807
Shuji YasuikeSchool of Pharmaceutical Sciences, Aichi Gakuin University, 1-100 Kusumoto-cho, Chikusa-ku, Nagoya 464-8650, Japan.ORCID https://orcid.org/0000-0001-9232-5205

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Unsymmetrical diaryl selenides bearing heteroaromatic moieties have attracted increasing attention because of their notable biological activities. In this paper, a novel bismuth-catalyzed three-component reaction is reported for the synthesis of 3-selanylimidazopyridines from imidazopyridines, arylboronic acids, and elemental selenium. The reaction proceeded under aerobic conditions at 100 °C using BiI

Indexed as

3-selanylimidazopyridinearylboronic acidbismuth catalystseleniumthree-component reaction

Identifiers

PMID42712735
PMCPMC13550849

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.